Relationship between impaired sensitivity to thyroid hormones and MAFLD with elevated liver enzymes in the euthyroid population

Author:

Zeng Haixia1,Liu Jianping1,Zhang Yuying1

Affiliation:

1. The Second Affiliated Hospital of Nanchang University

Abstract

Abstract Aims To investigate the association between thyroid hormone sensitivity and metabolic dysfunction-associated fatty liver disease (MAFLD) with elevated liver enzymes in the euthyroid populations. Methods A total of 3929 euthyroid adults from the Second Affiliated Hospital of Nanchang University were included in this study. Thyroid hormone sensitivity indices were calculated by thyroid feedback quantile-based index (TFQI), TSH index (TSHI) and thyrotropin thyroxine resistance index (TT4RI). Associations between thyroid hormones sensitivities and risk of MAFLD, MAFLD with elevated liver enzymes, MAFLD with elevated free fatty acid (FFAs) were assessed with logistic regression. Results After adjustment for multiple risk factors, odd ratios (ORs) of the fourth versus the first TFQIFT4 quartile for MAFLD, MAFLD with elevated liver enzymes, and MAFLD with elevated FFAs were 1.778 (95% CI 1.378, 2.293), 1.466 (1.105, 1.945), and 1.936 (1.479, 2.534), respectively (all p < 0.001). Per 1 SD in TFQIFT4, ORs increased 2.27 (95% CI 1.74, 2.97) for MAFLD, 2.05 (1.51, 2.78) for MAFLD with elevated liver enzymes, and 2.43 (1.82, 3.24) for MAFLD with elevated FFAs. The other sensitivity to thyroid hormones indices showed similar associations for MAFLD and MAFLD with elevated liver enzymes. Conclusions Impaired sensitivity to thyroid hormone in euthyroid population is associated with MAFLD, MAFLD with elevated liver enzymes, T2DM, hyperuricemia, elevated liver enzymes, and MAFLD with elevated FFAs. TFQIFT4, TFQIFT3, TSHI and TT4RI can be used as new indicators for predicting MAFLD and MAFLD with elevated liver enzymes, While TFQIFT3 performed better than the other three indexes.

Publisher

Research Square Platform LLC

Reference29 articles.

1. Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The lancet. Gastroenterology & hepatology. (2022)7:851–861.

2. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement;Eslam M;Journal of hepatology,2020

3. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L,Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, Md.). (2016)64:73–84.

4. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches;Schuppan D;Journal of gastroenterology and hepatology,2013

5. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system;Reddy JK;Annual review of nutrition.,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3